Efficacy and Safety of Zimberelimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of GLS-010 (Zimberelimab) in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Phase II Study
Eur. J. Cancer 2021 Aug 27;[EPub Ahead of Print], N Lin, M Zhang, H Bai, H Liu, J Cui, X Ke, H Zhang, L Liu, D Yan, Y Jiang, A Zang, J Qi, L Wang, Z Liu, B Xu, Y Zhang, Z Zhang, X Zhao, C Hu, S Yang, H Zhou, J Shi, Z Shao, Y Xiang, J Zhu, Y Song, J ZhuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.